CLINICAL TRIALS PROFILE FOR SUMATRIPTAN SUCCINATE
✉ Email this page to a colleague
All Clinical Trials for Sumatriptan Succinate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00329355 ↗ | Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) | Completed | GlaxoSmithKline | Phase 3 | 2006-05-01 | This study was designed to determine efficacy of TREXIMET (sumatriptan/naproxen sodium), formerly known as TREXIMA compared to placebo for the treatment of a menstrual migraine. |
| NCT00329459 ↗ | Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea | Completed | GlaxoSmithKline | Phase 3 | 2006-05-01 | This study was designed to determine efficacy of TREXIMA compared to placebo for the treatment of a menstrual migraine. |
| NCT00356603 ↗ | Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan | Completed | GlaxoSmithKline | Phase 3 | 2006-06-20 | This study will be conducted to collect cases treated by self-injection of sumatriptan 3mg kit product for the treatment of migraine or cluster headache attacks in clinical settings, to demonstrate the efficacy, and to examine patient acceptability (simplicity and usefulness) and rate of successful self-injection. |
| NCT00382993 ↗ | A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2) | Completed | GlaxoSmithKline | Phase 3 | 2006-12-01 | This is a randomized, double-blind, placebo-controlled, crossover, two-attack, out-patient, early-intervention evaluation of subjects who have migraine with or without aura and who discontinued use of short acting triptan(s) within the past year due to non-response or intolerance. Subjects will treat 2 separate migraine attacks during the mild phase of each attack; one attack will be treated with one tablet of the Combination Product (sumatriptan succinate and naproxen sodium) and the other attack with one tablet of placebo (crossover design). [Study 2 of 2] |
| NCT00383162 ↗ | A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2) | Completed | GlaxoSmithKline | Phase 3 | 2006-11-01 | This is a randomized, double-blind, placebo-controlled, crossover, two-attack, out-patient, early-intervention evaluation of subjects who have migraine with or without aura and who discontinued use of short acting triptan(s) within the past year due to non-response or intolerance. Subjects will treat 2 separate migraine attacks during the mild phase of each attack; one attack will be treated with one tablet of the Combination Product (sumatriptan succinate and naproxen sodium) and the other attack with one tablet of placebo (crossover design). [Study 1 of 2] |
| NCT00387881 ↗ | TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1) | Completed | GlaxoSmithKline | Phase 3 | 2006-09-01 | This study was designed to determine the efficacy and tolerability of TREXIMET (formerly known as TREXIMA) compared to placebo for the acute treatment of probable migraine, a sub-type of migraine. |
| NCT00434083 ↗ | To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches | Completed | POZEN | Phase 3 | 2004-07-01 | - to demonstrate the superiority of Trexima (combination of sumatriptan as the succinate 85 mg and naproxen sodium 500 mg) versus placebo in the acute treatment of migraine - to demonstrate the superiority of Trexima versus the individual components (sumatriptan as the succinate 85 mg and naproxen sodium 500 mg), and - to evaluate the safety of the Trexima. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Sumatriptan Succinate
Condition Name
Clinical Trial Locations for Sumatriptan Succinate
Trials by Country
Clinical Trial Progress for Sumatriptan Succinate
Clinical Trial Phase
Clinical Trial Sponsors for Sumatriptan Succinate
Sponsor Name
